======= ZC3H4 =======
== Gene Information ==
* **Official Symbol**: ZC3H4
* **Official Name**: zinc finger CCCH-type containing 4
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=23211|23211]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q9UPT8|Q9UPT8]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=ZC3H4&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ZC3H4|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/619498|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: This gene encodes a member of a family of CCCH (C-x8-C-x5-C-x3-H type) zinc finger domain-containing proteins. These zinc finger domains, which coordinate zinc finger binding and are characterized by three cysteine residues and one histidine residue, are nucleic acid-binding. Other family members are known to function in post-transcriptional regulation. [provided by RefSeq, Aug 2011].
* **UniProt Summary**: N/A
No Pfam Domain information is available for this gene.
|RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding|
|DNA-binding transcription factor activity|
|negative regulation of transcription, DNA-templated|
|negative regulation of nucleic acid-templated transcription|
|negative regulation of RNA biosynthetic process|
|negative regulation of RNA metabolic process|
|negative regulation of cellular macromolecule biosynthetic process|
|RNA binding|
|negative regulation of nucleobase-containing compound metabolic process|
|negative regulation of macromolecule biosynthetic process|
|negative regulation of cellular biosynthetic process|
|negative regulation of biosynthetic process|
|DNA-binding transcription factor activity, RNA polymerase II-specific|
|negative regulation of gene expression|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp440|Aphidicolin 0.4μM R08 exp440]]|1.73|
|[[:results:exp346|CoCl2 18μM R07 exp346]]|1.76|
|[[:results:exp227|Cryptotanshinone 12μM R05 exp227]]|1.79|
|[[:results:exp122|Golgicide-A 4μM R03 exp122]]|1.8|
|[[:results:exp535|Trimetrexate 0.03μM R08 exp535]]|1.81|
|[[:results:exp343|Centrinone 0.5μM R07 exp343]]|1.96|
|[[:results:exp45|Docetaxel 0.002μM R01 exp45]]|2.18|
|[[:results:exp49|NFN1 0.1μM R01 exp49]]|2.19|
|[[:results:exp180|Dynasore 10μM R04 exp180]]|2.39|
^Gene^Correlation^
|[[:human genes:r:rrm1|RRM1]]|0.546|
Global Fraction of Cell Lines Where Essential: 1/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|1/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 1365
* **Expression level (log2 read counts)**: 6.89
{{:chemogenomics:nalm6 dist.png?nolink |}}